Search

Seven students have successfully defended their dissertations and will receive their PhD degrees at commencement on May 18.

Learn more about a new radiopharmaceutical treatment for prostate cancer approved by the FDA for more patients.

Eric Alonzo successfully defended his thesis in September 2011. He completed his dissertation research in the laboratory of Dr. Derek Sant'Angelo in the Immunology Program.

Dinshaw J. Patel, a Member in Sloan Kettering Institute's Structural Biology Program and incumbent of the Abby Rockefeller Mauzé Chair in Experimental Therapeutics, was elected to the National Academy of Sciences at its 146th annual meeting in April.

MSK researchers discover a possible reason why people with kidney cancer respond better to treatments such as immunotherapy if they are obese.

MSK 斯隆的研究人员发现了肾癌患者在肥胖的情况下对免疫疗法等治疗反应更好的一个可能原因。MSK 斯隆的研究人员发现了肾癌患者在肥胖的情况下对免疫疗法等治疗反应更好的一个可能原因。

African American patients with colorectal cancer are less likely to have tumors that respond well to newer treatments such as targeted therapy and immunotherapy.

It can be hard to understand all the various radiation therapy options for prostate cancer. Here, we explain.